Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum
about
Methamphetamine toxicity and messengers of deathRole of monoamine transporters in mediating psychostimulant effectsNeuropharmacological mechanisms underlying the neuroprotective effects of methylphenidateComputational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration.meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine releaseLobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.HIV-1 gp120 and drugs of abuse: interactions in the central nervous systemDose-dependent attenuation of heroin self-administration with lobeline.Methamphetamine toxicity and its implications during HIV-1 infection.Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation.Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatumEnhanced neurodegeneration after a high dose of methamphetamine in adenosine A3 receptor null mutant miceCauses and consequences of methamphetamine and MDMA toxicity.The effect of a novel VMAT2 inhibitor, GZ-793A, on methamphetamine reward in rats.The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits.Differential regional effects of methamphetamine on dopamine transport.Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters.Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications.Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration.Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivoCholinergic functioning in stimulant addiction: implications for medications development.
P2860
Q24647617-4D12B4A0-526D-4967-B281-A5D4D48956EFQ24647948-35D67198-26AD-490B-8018-6119D62075A7Q24658233-91279431-16D9-4F6B-AE1F-38A020125D6AQ28290902-2CF4C723-1953-4BD7-A604-5727C1A11CC9Q30443801-886E1C3B-4FEF-4220-AE10-058003313A2EQ30498938-C7431C4C-BFB8-4F6B-928B-D0787D232DD9Q33613631-932C1992-6AF9-44C9-8352-87DDD99735ACQ33738102-CAD35F0A-41C2-4038-A508-50D678C835A4Q33861553-CB247F72-D530-4EA9-8FFF-56E11EE5F015Q33958021-8CB6B020-A73E-4230-815F-E8BA273D6BECQ33985461-1D18E059-EC00-4A1E-AA93-F2130D2242DBQ34214699-EF6E3B3F-84CE-4E90-A92D-C37F0B59F80AQ34673305-CA4215F4-8A98-4DB8-9E0D-C776B4BA54A8Q34760266-B7251271-CD9D-455D-8B4E-5CFAACA65A00Q35153060-BBD36887-B5EB-4EF7-860C-AD34449692F6Q35569786-691F3876-DD4A-445D-BDAA-615093586AA0Q35594881-EF11B453-ABDA-4A57-A632-4C3997ADB468Q36079830-AE20B23B-33BD-4594-890A-8746E7446D44Q36717509-0B3C2913-DBCE-4B0A-9E06-FFE3F180C536Q36968822-585D95AE-71FD-4FD6-97B3-948614C86D7AQ37052442-ABF36421-DF4D-4CF5-B341-4375A9969061Q37081344-E1BFD72C-0692-4142-ADD8-3E7A1E079B6AQ37190441-26880956-6A09-4DE9-B4C0-9DB736022979Q37227997-51370AFF-3907-4E37-8C4F-89F9F1494997Q37618780-B01BD987-C045-4D07-AB87-8B557C7FE922
P2860
Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Lobeline attenuates methamphet ...... ine depletions in the striatum
@ast
Lobeline attenuates methamphet ...... ine depletions in the striatum
@en
Lobeline attenuates methamphet ...... ine depletions in the striatum
@nl
type
label
Lobeline attenuates methamphet ...... ine depletions in the striatum
@ast
Lobeline attenuates methamphet ...... ine depletions in the striatum
@en
Lobeline attenuates methamphet ...... ine depletions in the striatum
@nl
prefLabel
Lobeline attenuates methamphet ...... ine depletions in the striatum
@ast
Lobeline attenuates methamphet ...... ine depletions in the striatum
@en
Lobeline attenuates methamphet ...... ine depletions in the striatum
@nl
P356
P1476
Lobeline attenuates methamphet ...... ine depletions in the striatum
@en
P2093
Bryan K Yamamoto
David J Eyerman
P356
10.1124/JPET.104.072264
P407
P577
2005-01-01T00:00:00Z